Transport and metabolism of MitoQ10, a mitochondria-targeted antioxidant, in Caco-2 cell monolayers

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 4, 2007, Pages 503-511

  Li, Yan ^a   Fawcett, J Paul ^a   Zhang, Hu ^a   Tucker, Ian G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BOVINE SERUM ALBUMIN; CYCLOSPORIN A; DRUG METABOLITE; GLYCOPROTEIN P; INDOMETACIN; MITOQUINOL GLUCURONIDE; MITOQUINOL SULFATE; MITOQUINONE MESYLATE; RESERPINE; UNCLASSIFIED DRUG; VERAPAMIL; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; MITOQUINOL; MITOQUINONE; ORGANOPHOSPHORUS COMPOUND; TUMOR PROTEIN; UBIQUINONE;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CANCER CELL; CELL MEMBRANE PERMEABILITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG PENETRATION; DRUG RESEARCH; DRUG STRUCTURE; DRUG TRANSPORT; HUMAN; HUMAN CELL; MITOCHONDRION; NONHUMAN; BIOAVAILABILITY; CELL STRAIN CACO 2; PERMEABILITY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANTIOXIDANTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CACO-2 CELLS; HUMANS; NEOPLASM PROTEINS; ORGANOPHOSPHORUS COMPOUNDS; P-GLYCOPROTEIN; PERMEABILITY; SERUM ALBUMIN, BOVINE; UBIQUINONE;

EID: 34250156691     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.4.0004     Document Type: Article

References (42)

1. Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A. J., Murphy, M. P., Sammut, I. A. (2005) Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 19: 1088-1095
2. Artursson, P., Karlsson, J. (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175: 880-885
3. Artursson, P., Palm, K., Luthman, K. (2001) Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46: 27-43
4. Asin-Cayuela, J., Manas, A. R., James, A. M., Smith, R. A., Murphy, M. P. (2004) Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett. 571: 9-16
5. Aungst, B. J., Nguyen, N. N., Bulgarelli, J. P., Oates-Lenz, K. (2000) The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds. Pharm. Res. 17: 1175-1180
6. Beyer, R. E., Segura-Aguilar, J., Di Bernardo, S., Cavazzoni, M., Fato, R., Fiorentini, D., Galli, M. C., Setti, M., Landi, L., Lenaz, G. (1996) The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc. Natl. Acad. Sci. USA 93: 2528-2532
7. Bleyer, W. A., Danielson, M. (1999) Oral cancer chemotherapy in paediatric patients: obstacles and potential for development and utilisation. Drugs 58 (Suppl. 3): 133-140
8. Bogman, K., Zysset, Y., Degen, L., Hopfgartner, G., Gutmann, H., Alsenz, J., Drewe, J. (2005) P-glycoprotein and surfactants: effect on intestinal talinolol absorption. Clin. Pharmacol. Ther. 77: 24-32
9. Chikhale, P. J., Borchardt, R. T. (1994) Metabolism of L-alpha-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers - comparison with metabolism in vivo. Drug Metab. Dispos. 22: 592-600
10. DeMario, M., Ratain, M. (1998) Oral chemotherapy: rationale and future directions. J. Clin. Oncol. 17: 3362-3365
11. Doppenschmitt, S., Spahn-Langguth, H., Regardh, C. G., Langguth, P. (1999) Role of P-glycoprotein-mediated secretion in absorptive drug permeability: an approach using passive membrane permeability and affinity to P-glycoprotein. J. Pharm. Sci. 88: 1067-1072
12. Ebert, B., Seidel, A., Lampen, A. (2005) Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26: 1754-1763
13. Fisher, J. M., Wrighton, S. A., Calamia, J. C., Shen, D. D., Kunze, K. L., Thummel, K. E. (1999) Midazolam metabolism by modified Caco-2 monolayers: effects of extracellular protein binding. J. Pharmacol. Exp. Ther. 289: 1143-1150
14. Gan, L. S. L., Thakker, D. R. (1997) Applications of the Caco-2 model in the design and development of orally active drugs - elucidation of biochemical and physical barriers posed by the intestinal epithelium. Adv. Drug Deliv. Rev. 23: 77-98
15. Grundemann, D., Liebich, G., Kiefer, N., Koster, S., Schomig, E. (1999) Selective substrates for non-neuronal monoamine transporters. Mol. Pharmacol. 56: 1-10
16. James, A. M., Cocheme, H. M., Smith, R. A., Murphy, M. P. (2005) Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J. Biol. Chem. 280: 21295-21312
17. Jauslin, M. L., Meier, T., Smith, R. A. J., Murphy, M. P. (2003) Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J. 17: 1972-1974
18. Karczewski, J. M., Peters, J. G. P., Noordhoek, J. (1999) Quinone toxicity in DT-diaphorase-efficient and -deficient colon carcinoma cell lines. Biochem. Pharmacol. 57: 27-37
19. Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., Murphy, M. P. (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells. Antioxidant and anti-apoptotic properties. J. Biol. Chem. 276: 4588-4596
20. Krishna, G., Chen, K. W. J., Lin, C. C., Nomeir, A. A. (2001) Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2. Int. J. Pharm. 222: 77-89
21. Litman, T., Druley, T. E., Stein, W. D., Bates, S. E. (2001) From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol. Life Sci. 58: 931-959
22. Matsson, P., Bergstrom, C. A., Nagahara, N., Tavelin, S., Norinder, U., Artursson, P. (2005) Exploring the role of different drug transport routes in permeability screening. J. Med. Chem. 48: 604-613
23. Mulder, G. J. (1984) Sulfation - metabolic aspects. In: Bridges, J. W., Chasseaud, L. F. (eds) Progress in drug metabolism. Taylor & Francis Ltd, New York; 8, pp 35-100
24. Murphy, M. P., Smith, R. A. J. (2000) Drug delivery to mitochondria: the key to mitochondrial medicine. Adv. Drug Deliv. Rev. 41: 235-250
25. Nyholm, D. (2006) Pharmacokinetic optimisation in the treatment of Parkinson's disease: an update. Clin. Pharmacokinet. 45: 109-136
26. Petri, N., Tannergren, C., Rungstad, D., Lennernäs, H. (2004) Transport characteristics of fexofenadine in the Caco-2 cell model. Pharm. Res. 21: 1398-1404
27. Porteous, W. K., James, A. M., Sheard, P. W., Porteous, C. M., Packer, M. A., Hyslop, S. J., Melton, J. V., Pang, C.-Y., Wei, Y.-H., Murphy, M. P. (1998) Bioenergetic consequences of accumulating the common 4,977 bp mitochondrial DNA deletion. Eur. J. Biochem. 257: 192-201
28. Prueksaritanont, T., Gorham, L. M., Hochman, J. H., Tran, L. O., Vyas, K. P. (1996) Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metab. Dispos. 24: 634-642
29. Saha, P., Kou, J. H. (2002) Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers. Eur. J. Pharm. Biopharm. 54: 319-324
30. Sawada, G. A., Barsuhn, C. L., Lutzke, B. S., Houghton, M. E., Padbury, G. E., Ho, N. F. H., Raub, T. J. (1999) Increased lipophilicity and subsequent cell partitioning decrease passive transcellular diffusion of novel, highly lipophilic antioxidants. J. Pharmacol. Exp. Ther. 288: 1317-1326
31. Schwarz, U., Gramatte, T., Krappweis, J., Oertel, R., Kirch, W. (2000) P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. Int. J. Clin. Pharmacol. Ther. 38: 161-167
32. Sikic, B., Fisher, G., Lum, B., Halsey, J., Beketic-Oreskovic, L., Chen, G. (1997) Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother. Pharmacol. 40 (Suppl.): 13-19
33. Smith, R. A. J., Porteous, C. M., Gane, A. M., Murphy, M. P. (2003) Delivery of bioactive molecules to mitochondria in vivo. Proc. Natl. Acad. Sci. USA 100: 5407-5412
34. Stoof, J. C., Winogrodzka, A., van Muiswinkel, F. L., Wolters, E. C., Voorn, P., Groenewegen, H. J., Booij, J., Drukarch, B. (1999) Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy. Eur. J. Pharmacol. 375: 75-86
35. Sun, D., Lennernas, H., Welage, L., Barnett, J., Landowski, C., Foster, D., Fleisher, D., Lee, K., Amidon, G. (2002) Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm. Res. 19: 1400-1416
36. Suzuki, M., Suzuki, H., Sugimoto, Y., Sugiyama, Y. (2003) ABCG2 transports sulfated conjugates of steroids and xenobiotics. J. Biol. Chem. 278: 22644-22649
37. Troutman, M. D., Thakker, D. R. (2003) Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium. Pharm. Res. 20: 1210-1224
38. Wils, P., Warnery, A., Phung-Ba, V., Legrain, S., Scherman, D. (1994) High lipophilicity decreases drug transport across intestinal epithelial cells. J. Pharmacol. Exp. Ther. 269: 654-658
39. Xia, C. Q., Liu, N., Yang, D., Miwa, G., Gan, L. S. (2005) Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells. Drug Metab. Dispos. 33: 637-643
40. Yee, S. (1997) In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - fact or myth. Pharm. Res. 14: 763-766
41. Zhang, T. M., Jijakli, H., Malaisse, W. J. (1996) Nutritional efficiency of succinic acid and glutamic acid dimethyl esters in colon carcinoma cells. Am. J. Physiol. 270: G852-859
42. Zhang, L., Zheng, Y., Chow, M. S. S., Zuo, Z. (2004) Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm. 287: 1-12